SEC Form 4 · accession 0001628280-26-060179
Amneal Pharmaceuticals, Inc. · AMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew S Boyer
Officer — Executive Vice President
Period of report
Sep 1, 2026
Accepted (ET)
Sep 2, 2026 · 5:03 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001723128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 1, 2026 | G | 80,000 | $0.00 | D | 193,646 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a gift to trust for the benefit of certain family members whereby reporting person does not serve as trustee.